Recon: CMS unveils second list of drug price negotiations; Tarver warns on device supply chain vulnerabilities

• Medicare announces plan to negotiate prices of diabetes, weight loss drugs (STAT) (Endpoints)
• Biden pardons Fauci to preempt possible charges when Trump takes office (STAT)
• AstraZeneca, Daiichi Sankyo win first U.S. approval for key cancer drug (STAT)
• Trump finally finds a populist health care message in Kennedy’s MAHA (STAT)
• Online marketing for compounded GLP-1 drugs overstates benefits and underplays risks (STAT)

• Another US biotech emerges with drug candidate from China-based Keymed (Endpoints)
• WuXi AppTec sells medical device testing unit; Layoffs at Notch Therapeutics (Endpoints)
• EU plans ban on 'forever chemicals' in consumer products (Reuters)
• India's Biocon urges government to exempt cancer, rare-disease drugs from tax in budget (Reuters)
• Fierce Pharma Asia—AbbVie's $1B pact with Simcere; Takeda's launch map; Samsung Bio's growth plans (Fierce Pharma)

• Studies reveal a new biology of Huntington’s, renewing drugmaker interest in therapies (STAT)
• Sage sues Biogen days after $469M buyout offer (Endpoints)
• Novo claims high-dose Phase 3 Wegovy win but sales impact might be muted (Endpoints)
• JPM25: Acadia’s new CEO sets sights on company's first $1B year (Fierce Pharma)
• Novartis wins 11th-hour bid to block generic version of blockbuster heart med Entresto (Fierce Pharma)
• AstraZeneca's Calquence and Amgen's Lumakras clinch FDA label expansions (Fierce Pharma)
• Arvinas' inaugural commercial chief steps down, to be replaced in the interim by market access VP (Fierce Pharma)
• Analysts tip Eisai, Biogen and Lilly to drive eightfold explosion in Alzheimer's market value (Fierce Pharma)

• Tarver warns that US device supply chain vulnerabilities could harm patients (MedTech Dive)
• BD expands syringe, needle production capacity in Nebraska and Connecticut (MedTech Dive)
• UK NHS Must Capture Data For Next Generation Of AI In Healthcare (MedTech Insight)
• EU Launches First Specific Plan On Cybersecurity For Healthcare Providers (MedTech Insight)

• Dementia risk, higher than thought, requires a national strategy (STAT)
• Former Trump health official: Medicare should cover Wegovy — but not negotiate its price (STAT)
• Former surgeon general: Vaccine-preventable diseases are still a major threat (STAT)
• Biden administration moves to expand, preserve access to addiction treatments as term expires (STAT)
• US and Canada ease ban on French poultry imposed after bird flu vaccination (Reuters)
• Exclusive: Kennedy played key role in Gardasil vaccine case against Merck (Reuters)
• Feds accuse Walgreens of filling ‘millions’ of illegal opioid prescriptions (STAT)